Opioid-exposed newborns

When exposed to opioids before birth, some newborns experience painful withdrawal, including frantic breathing, racing heart rates, constant crying, and tremors.  Thanks to grants from the National Institute on Drug Abuse (NIDA), the FDA is currently reviewing our De Novo submission for the Prapela bassinet pad to treat newborns with neonatal opioid withdrawal syndrome or NOWS. 


Apnea of Prematurity

When preterm newborns stop breathing for 20 seconds or more, caffeine is prescribed more than any other treatment. Even after caffeine, most newborns continue to experience apneas, triggering alarms causing a rush to wake them up to get them breathing again. Prapela is developing an incubator pad that will reduce apneas without disrupting sleep.